About Phenomix Sciences
Phenomix Sciences is a private company based in Menlo Park, California. It has reported $8,550,000 raised in three offerings on Form D since February 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 2025 | Dec 29, 2025 | $2,500,002of $5.0M target | 4 | $625K | EquityRule 506(b) | Form D ↗ |
| Apr 15, 2024 | May 6, 2024 | $5,000,000target not set | 4 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Feb 8, 2023 | Feb 22, 2023 | $1,049,998of $5.0M target | 3 | $349K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $8,550,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Phenomix Sciences's Form D filed Dec 29, 2025.
Earlier filings also listed Michael Camilleri (director, last listed May 2024), Karl Ronn (director, last listed May 2024) and Mark Bagnall (executive officer and director, last listed Feb 2023).